SKF's Board takes next step in the listing of SKF Vertevo and convenes Extraordinary General Meeting

GOTHENBURG, Sweden, Sept. 7, 2026 /PRNewswire/ -- The Board of Directors of AB SKF has decided to propose the distribution and listing of SKF's Automotive business, SKF Vertevo, and convenes an Extraordinary General Meeting (EGM) to be held on 1 October 2026. Subject to approval by SKF's shareholders at the EGM and customary regulatory approvals, the listing of SKF Vertevo is expected to take place on Nasdaq Stockholm on 1 December 2026. Additional information regarding the proposed distribution and listing is found in the information brochure attached hereto and in the notice to the EGM published separately today on: https://www.skf.com/group/investors/corporate-governance/general-meetings.

As previously communicated, the strategic rationale and driver behind the separation and the Board's proposal is connected to SKF's and SKF Vertevo's different business models, end markets and success drivers. As standalone companies, each business is expected to be able to further sharpen its strategic focus, allocate capital according to its own priorities, and enhance its ability to create value for customers and shareholders.

"The proposed distribution and listing of SKF Vertevo marks yet another important milestone in the separation of the Automotive business. The Board believes that creating two independent, focused companies will unlock the full potential of both SKF and SKF Vertevo, supporting accelerated profitable growth and long-term value creation benefitting customers, employees and shareholders", says Hans Stråberg, Chair of SKF Board of Directors.

The proposal follows the previously communicated completion of the operational separation of the Automotive business, which operates as a standalone business within the SKF Group. The Board and management team of the future SKF Vertevo have now been established as part of the final preparations for the business to operate independently. Further information and CVs of the Board of Directors and the management team members are available in the information brochure.

As previously announced, Håkan Buskhe has been elected as Chair of the Board of Directors of SKF Vertevo. The other shareholder-elected Board members are Therese Friberg, Hock Goh, Philip Ahlgren, Jumana Al-Sibai, Ebba Bonde, Maria Hemberg and Kerstin Enochsson.

Further, Therese Friberg and Hock Goh have decided to resign from the Board of Directors of AB SKF.

The distribution of the shares in SKF Vertevo is expected to fulfil the requirements set out in the so-called "Lex Asea" rules and will therefore not be immediately taxable for individuals and limited liability companies that are Swedish tax residents.

Previous press releases on similar topics:

26 February 2026: SKF announces the future name of the Automotive business: SKF Vertevo [link to press release]

18 September 2025: Håkan Buskhe to be appointed Chair of the Board of SKF Automotive [link to press release]

17 September 2024: SKF initiates a separation of its Automotive business [link to press release]

Aktiebolaget SKF

(publ)

For further information, please contact:

Press Relations: Carl Bjernstam, +46 31-337 2517; +46 722 201 893; [email protected] 

Investor Relations: Sophie Arnius, +46 31-337 8072; +46 705 908 072; [email protected] 

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

Share this article

Securities Class Action Filed; Firm Investigating Allegations of Undisclosed Chinese Military Ties and Fraudulent AI Distillation Attacks

SAN FRANCISCO, Sept. 7, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP urges Alibaba Group Holding Limited (NYSE: BABA) investors who suffered substantial losses submit their losses now.

A securities fraud class action lawsuit has been filed against Alibaba, and investors are encouraged to contact the firm regarding potential recoveries and lead plaintiff rights. The case, captioned Wistisen v. Alibaba Group Holding Limited, et al., No. 1:26-cv-06654 (S.D.N.Y.), accuses Alibaba and certain of its executive officers of violating the Securities Exchange Act of 1934.

Class Period: June 26, 2025 – June 24, 2026

Lead Plaintiff Deadline: Oct. 5, 2026

Visit: www.hbsslaw.com/baba

Contact the Firm Now: [email protected]

                                       844-916-0895

View our latest video summary of the allegations: www.youtube.com/watch?v=Mt00-HjZs8U

Core Allegations

The lawsuit alleges that Alibaba and certain executives misrepresented and failed to disclose adverse facts pertaining to the Company's business which were known to Defendants or recklessly disregarded by them. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that:

- Under the National Defense Authorization Act (NDAA), any entities directly or indirectly controlled by or affiliated with the Chinese Ministry of Industry and Information Technology (MIIT) were considered a Chinese military company;

- Alibaba was directly or indirectly controlled by or affiliated with the MIIT;

- The risk of Alibaba carrying out distillation attacks against third- party AI models was not a mere hypothetical or inadvertent, but ongoing; and

- As a result, Defendants' public statements about Alibaba's business, operations, and prospects were materially false and/or misleading at all relevant times.

The Truth Emerges

The truth regarding Alibaba's regulatory exposure and illicit business practices was revealed through a series of partial corrective disclosures:

- June 8, 2026: The U.S. Department of Defense added Alibaba to its list of Chinese military companies under the NDAA due to its ties to the MIIT. On this news, Alibaba ADSs fell $4.69 per share, or 3.9%, over two trading sessions.

- June 24, 2026: Bloomberg reported that Anthropic alerted U.S. officials that Alibaba fraudulently accessed Anthropic's Claude AI models via thousands of fake accounts to execute unauthorized "distillation" attacks to train its own models. On this news, Alibaba ADSs fell $4.73 per share, or 4.7%, to close at $95.07 on June 25, 2026.

The complaint alleges that as a result of Defendants' misleading statements and omissions, investors suffered substantial losses when the artificial inflation was removed from the stock.

Hagens Berman's Investigation

"We are investigating whether Alibaba executives intentionally concealed the company's regulatory ties and engaged in fraudulent operational practices to mislead the market about its true risk profile and competitive position," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation of the alleged claims in the pending suit.

What Affected BABA Investors Should Do

If you purchased or acquired Alibaba securities between June 26, 2025, and June 24, 2026, and suffered significant financial losses, you have until October 5, 2026, to ask the court to appoint you as lead plaintiff. You do not need to seek lead plaintiff status to share in any potential recovery.

To learn more about your legal options, submit your information to Hagens Berman, visit www.hbsslaw.com/baba, call Reed Kathrein at 844-916-0895, or email [email protected].

Whistleblowers: Persons with non-public information regarding Alibaba should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

SOURCE Hagens Berman Sobol Shapiro LLP

Share this article

SAN FRANCISCO, Sept. 7, 2026 /PRNewswire/ -- Hagens Berman, a national law firm noted for its preeminent work in securities class action litigation, notifies investors in HDFC Bank Limited (NYSE: HDB) of a pending securities fraud class action.

- Class Period: July 17, 2023 – May 26, 2026

- Lead Plaintiff Deadline: Oct. 13, 2026

- Visit: www.hbsslaw.com/hdb

- Contact the Firm Now: [email protected] / 844-916-0895

HDFC Bank Limited (HDB) Securities Class Action Overview:

The lawsuit filed against HDFC Bank Limited ("HDFC" or the "Company"), and certain top executive officers including Chief Executive Officer Sashidhar Jagdishan and Chief Financial Officer Srinivasan Vaidyanathan, alleges violations of the federal securities laws.

Specifically, the action centers on HDFC's failure to disclose key material adverse facts regarding its business operations, financial accounting, and regulatory compliance:

- Camouflaged Marketing Payments & Covert Deposit Inducements: HDFC secretly funneled approximately Rs 45 crore (approx. $4.7 million USD) to the Maharashtra State Road Development Corporation ("MSRDC") to induce the state firm to place large deposits with the bank.

- Disguised Above-Market Interest Rates: To circumvent regulations and provide MSRDC with a 6.01% interest rate (a 2.51% markup over standard retail savings accounts), senior management devised a scheme to route the differential payments through the marketing department disguised as sponsorship contributions for a road safety awareness campaign.

- Governance and Regulatory Breaches: These covert practices violated the Reserve Bank of India's (RBI) Master Directions on interest rates and breached the bank's own internal anti-bribery and anti-corruption policies prohibiting improper inducements.

- Overstated Financials: As a result of these hidden activities, HDFC's interest income and operating expenses were overstated during the class period, rendering the Company's positive public statements and financial controls false and misleading.

Truth Begins to Unravel & Stock Price Declines:

The fraudulent scheme allegedly began to surface in stages, causing sharp drops in the market value of HDFC American Depositary Shares (ADS):

- March 18, 2026: HDFC announced the abrupt resignation of part-time Chairman and Independent Director Atanu Chakraborty, whose resignation letter stated that happenings and practices within the bank over the prior two years were "not in congruence with my personal Values and Ethics." On this news, HDFC ADS prices fell 7.28% on heavy volume.

- May 27, 2026: The Indian Express published an investigative report exposing that HDFC "camouflaged crores as marketing spend" to pay higher interest to MSRDC, revealing an internal vigilance probe implicating CEO Sashidhar Jagdishan and other top leadership. Following this disclosure, HDFC ADS fell 4.1% to close at $23.78 per share.

Hagens Berman's Investigation

"We're focused on whether HDFC's senior leadership concealed a covert scheme to funnel millions in disguised payments to induce state-firm deposits while publicly painting a picture of strong governance and compliance, as the complaint alleges," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation of the pending claims in the suit.

What Affected HDB Investors Should Do

If you purchased or acquired HDFC securities between July 17, 2023, and May 26, 2026, and suffered significant financial losses, you have until October 13, 2026, to ask the court to appoint you as lead plaintiff.

To learn more about your legal options, submit your information to Hagens Berman, visit www.hbsslaw.com/hdb, call Reed Kathrein at 844-916-0895, or email [email protected].

Whistleblowers: Persons with non-public information regarding HDFC should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

SOURCE Hagens Berman Sobol Shapiro LLP

Share this article

SAN FRANCISCO, Sept. 7, 2026 /PRNewswire/ -- UWM Holdings Corporation (NYSE: UWMC) faces a securities class action lawsuit after the price of their shares cratered 34% on August 6, 2026 in response to revelations that the company suffered over a $603 million hedge loss associated with its failed bid to acquire Two Harbors Investment Corp. and, as a result, agreed to a plan to massively dilute existing shareholders.

Hagens Berman is investigating the alleged claims and encourages UWM investors who suffered substantial losses to submit your losses now.

Key Details

Class Period: Mar. 9, 2026 – Aug. 5, 2026

Lead Plaintiff Deadline: Oct. 13, 2026

Visit: www.hbsslaw.com/uwmc

Contact the Firm Now: [email protected]

                                        844-916-0895

UWM Holdings Corporation (UWMC) Securities Class Action:

The suit centers on UWM's disclosures about its hedging strategy in connection with its attempt to acquire Two Harbors.

On December 17, 2025, mortgage lender UWM announced that it and mortgage servicing rights ("MSR") company Two Harbors entered into a merger agreement pursuant to which UWM would acquire Two Harbors for about $1.3 billion in UWM stock. Two Harbors was free to receive proposals superior to UWM's.

In connection with the proposed acquisition, UWM entered into significant hedging transactions against Two Harbors' MSR portfolio whose value typically and rapidly changes based on interest rates and homeowner refinancing speeds.

The complaint alleges that UWM did not disclose that it over-hedged in connection with its attempt to take over Two Harbors. The danger to this is that if an acquisition falls through the massive hedge left behind can turn into a speculative gamble.

Over four months ago, on March 27, 2026, Two Harbors announced that it entered a definitive merger agreement with CrossCountry Mortgage in a cash transaction and that it terminated its previous deal with UWM and would pay UWM the termination fee.

Although UWM had disclosed certain information about having hedged the transaction before March 27, investors did not learn the truth of the company's exposure until August 6, 2026. That day UWM reported three important things.

First, the company reported a massive $451 million net loss and roughly a $603 million hedging loss. Management revealed, apparently for the first time, that "we were over-hedged" and "obviously, the Two Harbors transaction went away."

Second, UWM disclosed that its total equity sequentially plunged by about $615 million, or a whopping 38%.

On top of that and third, UWM told shareholders in essence that, as a result of the foregoing, it entered into a massively dilutive recapitalization plan.

The market swiftly reacted, sending the price of UWM shares sharply lower that day. Between December 17, 2025, the day of the Two Harbors acquisition announcement, and August 6, 2026, the price Of UWM shares has declined by about $3.65 or 75%.

Hagens Berman's Investigation

"We're focused on UWM's explanations for why it refrained from unwinding its hedges months ago and why management seemingly went virtually silent on the naked hedging risks until recently," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.

If you invested in UWM and have substantial losses, or have knowledge that will assist the firm's investigation, submit your losses now »

Whistleblowers: Persons with non-public information regarding UWM should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

SOURCE Hagens Berman Sobol Shapiro LLP

Share this article

Matthias Bellino zahajuje novou offroadovou kapitolu díky Segway Powersports

PAŘÍŽ, 7. září 2026 /PRNewswire/ -- Francouzský šampion v enduru Mathias Bellino zahajuje novou kapitolu svého offroadového příběhu díky podpoře značky Segway Powersports, která jej vybavila čtyřkolkou Super Villain SX20T. Toto partnerství přináší Bellinovi nové příležitosti, jak zůstat v kontaktu s terénem, výzvami a objevováním neznáma, které utvářely jeho život v motosportu.

Bellino je vítězem Světového mistrovství juniorů v enduru (Enduro Junior World Championship) za rok 2012 a mistrovství v enduru E3 (Enduro E3 World Championship) za rok 2015. Byl také členem francouzského týmu, který vyhrál světový pohár juniorů ISDE (ISDE Junior World Trophy) v letech 2011-2013. Pochází z rodiny vyznávající hlubokou vášeň k motocyklům, na nichž začal jezdit již ve čtyřech letech a později se posunul k motokrosu a enduru na nejvyšší úrovni.

V srpnu 2018, kdy usiloval o účast na Dakar Rally, utrpěl při svém prvním etapovém závodě Desafío Ruta 40 nehodu s následkem vážného zranění páteře. Neštěstí sice ukončilo jeho profesionální závodní kariéru, ne však jeho vztah k motosportu. Později se vrátil do padoku EnduroGP jako manažer týmu Honda ORC a stále nachází nové způsoby, jak zůstat součástí offroadové komunity.

Se čtyřkolkou Super Villain SX20T nyní Bellino odhaluje novou příležitost k offroadovým zážitkům v terénu. Tato side by side čtyřkolka klade důraz právě na to, co ho k tomuto sportu vždy lákalo: pobyt venku, poznávání krajiny a sdílení zážitků s ostatními.

Pro Bellina není tato kapitola opakováním minulosti, ale další cestou vpřed podle vlastních pravidel. Značka Segway Powersports s ním sdílí víru v objevování neznáma a pod heslem Fear No Place (Nebát se nikam) jeho cestu podporuje.

O Segway Powersports

Společnost Segway je světovou jedničkou v oblasti mikromobility, powersportů a spotřebitelských robotů, proslulou svými inovacemi a důrazem na spotřebitele. Značka Segway Powersports se zaměřuje na vývoj a výrobu nové generace vozidel pro powersporty, včetně čtyřkolek ATV (all terrain vehicles) a SxS (side by side) pro pracovní i sportovní účely. Jako hi-tech společnost propojuje Segway Powersports robustní dodavatelský řetězec s vlastními výrobními kapacitami a spravuje celý životní cyklus výrobku od R&D a výroby až k prodeji a poprodejním službám.

Další informace najdete na https://powersports.segway.com.

Share this article

SAN FRANCISCO, Sept. 7, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, a national shareholder rights firm, notifies investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) of a pending securities class action lawsuit.

Investors who purchased or acquired Aardvark common stock pursuant and/or traceable to the offering documents issued in connection with the Company's initial public offering (IPO) on or about February 13, 2025, and/or purchased or acquired Aardvark securities between February 13, 2025 and May 14, 2026 (the Class Period), are encouraged to contact our firm now.

Watch our video on the Aardvark investigation: youtu.be/pY5E36QoCqo

Key Case Details & Important Deadlines

- Lead Plaintiff Motion Deadline: October 13, 2026

- Visit: www.hbsslaw.com/aard

- Contact the Firm Now: [email protected]

844-916-0895

What is the Lawsuit About?

The complaint alleges that Aardvark Therapeutics, a clinical-stage biopharmaceutical company focused on developing small-molecule therapies targeting bitter taste receptors (TAS2Rs) such as ARD-101 for the treatment of hyperphagia in Prader-Willi Syndrome (PWS), made materially false and misleading statements and/or failed to disclose critical information.

Specifically, the action points out that the offering documents and defendants failed to disclose:

- That ARD-101 was significantly less safe than defendants had led investors to believe;

- That unexpected, reversible cardiac observations (such as QRS prolongation) occurred during trials at above-target doses; and

- Consequently, Aardvark's clinical, regulatory, and commercial prospects—including the Phase 3 Hunger Elimination or Reduction Objective (HERO) trial and open-label extension (OLE)—were materially overstated.

The Truth Emerges: Voluntarily Pause and FDA Clinical Hold

- February 27, 2026: Aardvark announced it was voluntarily pausing its Phase 3 HERO trial due to "reversible cardiac observations at above target therapeutic doses found during routine safety monitoring in a healthy volunteer study." Following this news, Aardvark's stock price plummeted over 56%.

- May 14, 2026: Aardvark announced that the U.S. Food and Drug Administration (FDA) placed a full clinical hold on its investigational new drug application (IND) for ARD-101, halting all ongoing studies under the IND, including the Phase 3 HERO trial and OLE trial. Aardvark's stock price fell another 32.1%.

Hagens Berman's Investigation

"We're investigating the suit's allegations, including that Aardvark allegedly misled investors about ARD-101's development, its safety and efficacy," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation of the claims in the pending suit.

What Can Aardvark Investors Do?

If you are a class member who suffered losses on Aardvark securities, you have until October 13, 2026, to ask the Court to appoint you as Lead Plaintiff for the class. The firm welcomes AARD investors to contact the firm to discuss their legal rights and potential recovery options.

- Submit Your Information to Hagens Berman

- Contact an Attorney: [email protected]

844-916-0895

If you'd like more information and answers to frequently asked questions about the firm's Aardvark investigation, read more »

Whistleblowers: Persons with non-public information regarding Aardvark Therapeutics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

SOURCE Hagens Berman Sobol Shapiro LLP

Share this article

SAN FRANCISCO, Sept. 7, 2026 /PRNewswire/ -- Innventure, Inc. (NASDAQ: INV) and certain executives face a securities class action lawsuit after its stock price cratered 55% on August 14, 2026, triggered by the company's decisions to remove the DarkNX project from its 2026 forecast and suspend its revenue guidance.

As a result of these developments, national shareholders rights firm Hagens Berman is investigating claims that Innventure violated the federal securities laws. The firm encourages Innventure investors who suffered substantial losses to submit your losses now.

Class Period: Nov. 17, 2025 – Aug. 13, 2026

Lead Plaintiff Deadline: Oct. 27, 2026

Visit: www.hbsslaw.com/inv

Contact the Firm Now: [email protected]

                                         844-916-0895

Innventure, Inc. ($INV) Securities Class Action:

The litigation is focused on the propriety of Innventure's statements about Accelsius' arrangement with DarkNX, a purported global digital infrastructure company, under which DarkNX would deploy Accelsius' NeuCool technology across a new 300MW AI data center campus in Ontario, Canada.

More specifically, the company has characterized the project as "the largest two-phase, direct-to-chip deployment to date, signaling a major shift toward large-scale industry adoption of next-generation cooling." In addition, during the Class Period, Innventure assured investors that the DarkNX project is "proceeding as expected with initial deliveries expected in 2026."

The company's narrative began to come into question on May 28, 2026. That day, forensic research firm Morpheus Research published "Innventure: The Latest Iteration Of A Decades-Long Grift Propped Up By A Fake 300MW Data Center Deal." According to the Morpheus report, there was "zero evidence this project exists or that DarkNX has the team or funding to even contemplate such a project."

The report said "[a]ccording to a former Innventure executive, management was using 'false information' and revenue projections that were 'pure fiction' to solicit investments into Accelsius." Quoting a former Accelsius employee, when asked about DarkNX, the former employee reportedly said "'we've never heard of the company'" and "'there's no data center.'"

On August 13, 2026, Innventure's narrative fully unraveled, when the company revealed "that the deployment site identified in the DarkNX purchase order is no longer available." Accordingly, the company removed the DarkNX project from its internal bookings and suspended its 2026 revenue and cash flow expectations.

As a result of these revelations, between May 27, 2026 (the day before Morpheus' report) and August 14, 2026, the price of Innventure shares crumbled $4.795, or a whopping 74%.

"We're focused on whether Innventure may have intentionally or recklessly misled its shareholders about the viability of the DarkNX project," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.

If you invested in Innventure and have substantial losses, or have knowledge that will assist the firm's investigation, submit your losses now »

Whistleblowers: Persons with non-public information regarding Innventure should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

SOURCE Hagens Berman Sobol Shapiro LLP

Share this article

SAN FRANCISCO, Sept. 7, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct.

Hagens Berman, which is actively investigating the alleged claims, encourages HIMS investors who suffered substantial losses to submit your losses now.

Class Period: Aug. 4, 2025 – July 29, 2026

Lead Plaintiff Deadline: Nov. 2, 2026

Visit Hims Investigation Page: www.hbsslaw.com/hims

Direct Contact Email: [email protected]

Firm Telephone: 844-916-0895

Hims & Hers Health ($HIMS) Securities Class Action

The lawsuit is focused on the propriety of Hims' repeated assurances that "[w]e have developed and maintain policies and procedures with respect to health information and personal information that we use or disclose in connection with our operations, including the adoption of administrative, physical, and technical safeguards to protect such information."

The complaint alleges that Hims: (1) shared consumers' health information with third-party advertising platforms; (2) charges consumers for prescriptions almost immediately after they submit intake forms, despite telling them that they will be able to consult with a medical provider to find a treatment that is "right for them[;]" and (3) as a result, would be subject to heightened regulatory scrutiny and likely to incur fees and penalties.

What Drove the $HIMS July 29, 2026 Stock Crash? The FTC and State Lawsuit Breakdown

The securities class action cites the July 29, 2026 federal complaint filed against Hims by the FTC—alongside co-plaintiffs the State of Utah and the County of Los Angeles (representing California).

After an extensive investigation by the Commission, it contends that Hims engaged in:

- Deceptive Health Data Sharing: Despite extensive marketing campaigns emphasizing strict privacy, discreet telehealth consultations, and data protection, the complaint alleges that Hims surreptitiously shared sensitive user medical conditions and personal health data with third-party advertising giants, including Meta Platforms (Facebook) and Snap, via embedded tracking pixels and customer list matching.

- Subscription Billing & Cancellation Barriers (ROSCA Violations): The lawsuit accuses Hims of violating the Restore Online Shoppers' Confidence Act (ROSCA) by enrolling consumers in recurring subscription models without informed consent. According to regulators, consumers were billed for prescriptions almost immediately upon completing an intake form—long before receiving any consultation with a medical provider—while facing dark patterns and hidden cancellation options designed to prevent subscription termination.

The market swiftly reacted, sending the price of Hims shares down $4.32 (-14.7%) and erasing over $970 million from the company's market capitalization in a single day.

"We're focused on whether Hims may have intentionally misled investors about its business practices, including the adequacy of its internal controls, and financial ramifications of the alleged misconduct," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.

If you invested in HIMS and have substantial losses, or have knowledge that will assist the firm's investigation, submit your losses now »

Whistleblowers: Persons with non-public information regarding HIMS should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.

SOURCE Hagens Berman Sobol Shapiro LLP

Share this article

Mathias Bellino rozpoczyna nowy rozdział swojej przygody z jazdą terenową przy wsparciu Segway Powersports

PARYŻ, 7 września 2026 r. /PRNewswire/ -- Francuski mistrz enduro Mathias Bellino rozpoczyna nowy rozdział swojej przygody z jazdą terenową przy wsparciu Segway Powersports, które przekazało mu pojazd Super Villain SX20T. Współpraca daje Bellino nowy sposób na bycie blisko terenu, podejmowanie wyzwań i karmienie ducha odkrywcy, które przez lata kształtowały jego życie w sportach motorowych.

Bellino zdobył tytuł mistrza świata juniorów w enduro w 2012 r. oraz mistrza świata Enduro E3 w 2015 r. Był również członkiem reprezentacji Francji, która przez trzy kolejne lata, od 2011 do 2013 r., zdobywała ISDE Junior World Trophy. Wychował się w rodzinie silnie związanej z motocyklami. Zaczął jeździć w wieku czterech lat, a następnie rozwijał karierę poprzez motocross aż do rywalizacji na najwyższym poziomie w enduro.

W sierpniu 2018 r., podczas swojego pierwszego rajdu cross-country, Desafío Ruta 40 w Argentynie, Bellino uległ wypadkowi, w wyniku którego doznał poważnych urazów kręgosłupa. W tym czasie przygotowywał się do realizacji swojego celu, jakim był start w Rajdzie Dakar. Wypadek zakończył jego zawodową karierę wyścigową, ale nie jego związek ze sportami motorowymi. Później wrócił do padoku EnduroGP jako menedżer zespołu Honda ORC i nadal znajdował nowe sposoby, by pozostawać aktywną częścią środowiska off-roadowego.

Dzięki Super Villain SX20T Bellino odkrywa teraz nowy sposób przeżywania jazdy w terenie. Ten pojazd typu side-by-side pozwala mu skupić się na tym, co zawsze przyciągało go do tego sportu: przebywaniu na świeżym powietrzu, odczytywaniu ukształtowania terenu i dzieleniu tych doświadczeń z innymi.

Dla Bellino ten nowy etap nie polega na odtwarzaniu przeszłości, lecz na dalszym podążaniu naprzód na własnych zasadach. Segway Powersports wspiera go w tej drodze, opierając współpracę na wspólnej pasji do odkrywania i duchu „Fear No Place".

Segway Powersports

Segway jest światowym liderem w dziedzinie mikromobilności, pojazdów terenowych i rekreacyjnych (powersports) oraz robotyki konsumenckiej, znanym z innowacyjności i produktów projektowanych z myślą o użytkownikach. Segway Powersports koncentruje się w szczególności na projektowaniu i produkcji nowej generacji pojazdów rekreacyjno-użytkowych, w tym pojazdów terenowych ATV oraz pojazdów typu side-by-side (SxS), przeznaczonych zarówno do zastosowań użytkowych, jak i sportowych. Jako przedsiębiorstwo zaawansowanych technologii Segway Powersports łączy rozbudowany łańcuch dostaw z własnymi możliwościami produkcyjnymi, zarządzając całym cyklem życia produktów - od badań i rozwoju oraz produkcji po sprzedaż i obsługę posprzedażową.

Więcej informacji na stronie: https://powersports.segway.com.

Share this article

LOS ANGELES, Sept. 7, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Planet Fitness, Inc.

IF YOU SUFFERED A LOSS ON YOUR PLANET FITNESS, INC. INVESTMENTS, CLICK HERE BEFORE SEPTEMBER 14, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT

What Is The Lawsuit About? 

On May 7, 2026, Planet Fitness released its first quarter 2026 financial results, slashing same-store growth from 4-5% to only 1%, and completely withdrawing its long-term three-year growth algorithm it had introduced just six months prior, citing, among other things, an over-pivoted marketing campaign that failed to resonate with its core customer base, alongside external competition. The Company further disclosed that it was pausing its planned national rollout of its Black Card price increase to prioritize revitalizing new membership growth.

On this news, Planet Fitness's stock price fell $19.95, or 31.2%, to close at $44.01 per share on May 7, 2026, thereby injuring investors.

What's The Next Step?

Glancy Prongay Wolke & Rotter LLP is a leading national shareholder rights law firm, ready to assist you in potentially pursuing claims to recover your loss.

If you wish to serve as lead plaintiff, you must move the Court no later than September 14, 2026. Please contact us to learn more about your rights and interests by clicking here, by email ([email protected]), or by telephone at 310-201-9150 (Toll-Free: 888-773-9224).

You may retain counsel of your choice. If you bought securities during the class period, you may take no action and remain an absent class member. No class has been certified yet.

Why Glancy Prongay Wolke & Rotter LLP?

GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm's recent successes, GPWR was named one of Law360's Securities Groups of the Year and ranked 2nd in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR's lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR's past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money. Prior results do not guarantee a similar outcome.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us:

Glancy Prongay Wolke & Rotter LLP,

1925 Century Park East, Suite 2100,

Los Angeles, CA 90067

Charles Linehan

Email: [email protected]

Telephone: 310-201-9150

Toll-Free: 888-773-9224

Visit our website at: www.glancylaw.com.

SOURCE Glancy Prongay Wolke & Rotter LLP

Share this article